Editorial: Complexity of tumor microenvironment: A major culprit in cancer development, volume II.
作者信息
Bukhari Ihtisham, Zhang Yuanwei, Thorne Rick Francis, Mi Yang
机构信息
Henan Key Laboratory of Helicobacter pylori, Microbiota and Gastrointestinal Cancers, Marshall Medical Research Center, Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Translational Research Institute, Henan Provincial and Zhengzhou City Key Laboratory of Non-coding RNA and Cancer Metabolism, Henan International Join Laboratory of Non-coding RNA and Metabolism in Cancer, Henan Provincial People's Hospital, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, Henan, China.
出版信息
Front Endocrinol (Lausanne). 2023 Jan 12;13:1126778. doi: 10.3389/fendo.2022.1126778. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Complexity of tumor microenvironment: A major culprit in cancer development, volume II.社论：肿瘤微环境的复杂性：癌症发展的主要元凶，第二卷
Front Endocrinol (Lausanne). 2023 Jan 12;13:1126778. doi: 10.3389/fendo.2022.1126778. eCollection 2022.
2
Editorial: Complexity of tumor microenvironment: A major culprit in cancer development.社论：肿瘤微环境的复杂性：癌症发展的主要元凶
Front Endocrinol (Lausanne). 2022 Oct 20;13:1059885. doi: 10.3389/fendo.2022.1059885. eCollection 2022.
3
Editorial: Volume II: Tumor microenvironment in cancer hallmarks and therapeutics.社论：第二卷：癌症特征与治疗中的肿瘤微环境
Front Mol Biosci. 2023 Mar 28;10:1182083. doi: 10.3389/fmolb.2023.1182083. eCollection 2023.
4
Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy.识别基线免疫相关生物标志物，预测免疫治疗的临床结局。
J Immunother Cancer. 2017 May 16;5:44. doi: 10.1186/s40425-017-0243-4. eCollection 2017.
5
Immunotherapy improves disease prognosis by affecting the tumor microenvironment: A bibliometric study.免疫疗法通过影响肿瘤微环境来改善疾病预后：文献计量学研究。
Front Immunol. 2022 Oct 6;13:967076. doi: 10.3389/fimmu.2022.967076. eCollection 2022.
6
Comprehensive Analysis of Pyroptosis-Related Genes and Tumor Microenvironment Infiltration Characterization in Breast Cancer.乳腺癌中细胞焦亡相关基因的综合分析与肿瘤微环境浸润特征
Front Immunol. 2021 Sep 30;12:748221. doi: 10.3389/fimmu.2021.748221. eCollection 2021.
7
The Impact of NOTCH Pathway Alteration on Tumor Microenvironment and Clinical Survival of Immune Checkpoint Inhibitors in NSCLC.NOTCH 通路改变对 NSCLC 肿瘤微环境和免疫检查点抑制剂临床生存的影响。
Front Immunol. 2021 Jul 9;12:638763. doi: 10.3389/fimmu.2021.638763. eCollection 2021.
8
Multi-Omics Perspective Reveals the Different Patterns of Tumor Immune Microenvironment Based on Programmed Death Ligand 1 (PD-L1) Expression and Predictor of Responses to Immune Checkpoint Blockade across Pan-Cancer.多组学视角揭示基于程序性死亡配体 1（PD-L1）表达的肿瘤免疫微环境的不同模式和免疫检查点阻断反应的预测因子在泛癌中的差异。
Int J Mol Sci. 2021 May 13;22(10):5158. doi: 10.3390/ijms22105158.
9
[Biomarkers for Immunotherapy Based on the Local Microenvironment of Gastric Cancer].基于胃癌局部微环境的免疫治疗生物标志物
Gan To Kagaku Ryoho. 2020 Sep;47(9):1292-1297.
10
LATPS, a novel prognostic signature based on tumor microenvironment of lung adenocarcinoma to better predict survival and immunotherapy response.LATPS，一种基于肺腺癌肿瘤微环境的新型预后标志物，可更好地预测生存和免疫治疗反应。
Front Immunol. 2022 Nov 24;13:1064874. doi: 10.3389/fimmu.2022.1064874. eCollection 2022.
引用本文的文献
1
Dual Role of L. Extract in Breast Cancer Regression: Reestablishment of Effective Immune Response.L提取物在乳腺癌消退中的双重作用：有效免疫反应的重建。
Pharmaceuticals (Basel). 2024 Feb 23;17(3):286. doi: 10.3390/ph17030286.
本文引用的文献
1
New Insight into the Role of AhR in Lung Carcinogenesis.AhR 在肺癌发生中的作用新见解。
Biochemistry (Mosc). 2022 Nov;87(11):1219-1225. doi: 10.1134/S0006297922110013.
2
Structure, Function, and Inhibitors of the Mitochondrial Chaperone TRAP1.线粒体伴侣蛋白TRAP1的结构、功能及抑制剂
J Med Chem. 2022 Dec 22;65(24):16155-16172. doi: 10.1021/acs.jmedchem.2c01633. Epub 2022 Dec 12.
3
Immunosuppressive environment in response to androgen deprivation treatment in prostate cancer.前列腺癌雄激素剥夺治疗中的免疫抑制环境。
Front Endocrinol (Lausanne). 2022 Nov 24;13:1055826. doi: 10.3389/fendo.2022.1055826. eCollection 2022.
4
The role of tumor microenvironment reprogramming in primary liver cancer chemotherapy resistance.肿瘤微环境重编程在原发性肝癌化疗耐药中的作用
Front Oncol. 2022 Nov 24;12:1008902. doi: 10.3389/fonc.2022.1008902. eCollection 2022.
5
Advances in CAR T cell immunotherapy for paediatric brain tumours.儿童脑肿瘤的嵌合抗原受体T细胞免疫疗法进展
Front Oncol. 2022 Nov 23;12:873722. doi: 10.3389/fonc.2022.873722. eCollection 2022.
6
Unscheduled epigenetic modifications cause genome instability and sterility through aberrant R-loops following starvation.非计划性的表观遗传修饰通过饥饿后异常 R 环导致基因组不稳定和不育。
Nucleic Acids Res. 2023 Jan 11;51(1):84-98. doi: 10.1093/nar/gkac1155.
7
Cancer immunotherapy with CAR T cells: well-trodden paths and journey along lesser-known routes.嵌合抗原受体 T 细胞的癌症免疫疗法：踏过的熟路和未知的小径。
Radiol Oncol. 2022 Dec 13;56(4):409-419. doi: 10.2478/raon-2022-0049. eCollection 2022 Dec 1.
8
The molecular link between obesity and genomic instability in cancer development.肥胖与癌症发生过程中基因组不稳定之间的分子联系。
Cancer Lett. 2023 Feb 28;555:216035. doi: 10.1016/j.canlet.2022.216035. Epub 2022 Dec 9.
9
Efficacy, Safety, and Challenges of CAR T-Cells in the Treatment of Solid Tumors.嵌合抗原受体T细胞在实体瘤治疗中的疗效、安全性及挑战
Cancers (Basel). 2022 Dec 3;14(23):5983. doi: 10.3390/cancers14235983.
10
Non-Invasive Biomarkers for Early Lung Cancer Detection.用于早期肺癌检测的非侵入性生物标志物
Cancers (Basel). 2022 Nov 24;14(23):5782. doi: 10.3390/cancers14235782.
Zotero 插件